High affinity mAb infusion can enhance maximum affinity maturation during HIV Env immunization.
Immune response
Immunology
Virology
Journal
iScience
ISSN: 2589-0042
Titre abrégé: iScience
Pays: United States
ID NLM: 101724038
Informations de publication
Date de publication:
19 Apr 2024
19 Apr 2024
Historique:
received:
04
08
2023
revised:
27
11
2023
accepted:
09
03
2024
medline:
29
3
2024
pubmed:
29
3
2024
entrez:
29
3
2024
Statut:
epublish
Résumé
Antigen-specific antibody infusion is known to enhance or suppress germinal center (GC) responses depending on the affinity of the infusion. We hypothesized that infusing monoclonal antibodies (mAbs) of escalating affinity during an immunization regimen may progressively escalate selection pressure on competing B cells, increasing their affinity. To test this, we immunized mice with HIV envelope gp120 and infused CD4 binding-site (CD4bs)-specific mAbs. While mAb infusion reduced somatic hypermutation (SHM) and affinity in most CD4bs-specific B cells, a sub-population was identified with greater SHM and affinity than control. High-throughput sequencing of plasma cells revealed that CD4bs-specific plasma cells possessed elevated SHM after mAb infusion, with phylogenetic tree topology that suggested more rapid differentiation. We therefore conclude, in accordance with other studies, that high-affinity mAb infusion primarily suppresses recruitment of most competing B cells but can increase and expedite affinity maturation of certain epitope-specific B cells.
Identifiants
pubmed: 38550978
doi: 10.1016/j.isci.2024.109495
pii: S2589-0042(24)00716-8
pmc: PMC10973984
doi:
Types de publication
Journal Article
Langues
eng
Pagination
109495Informations de copyright
© 2024 The Authors.
Déclaration de conflit d'intérêts
R.P., J.P.A., D.H., A.B., W.T., T.W., and I.S.N. are employees and shareholders in GSK plc. No other authors have competing interests to declare.